IDO1 and neoplasm: Similarly, in spontaneous GISTs, imatinib inhibits the expression of the immunosuppressive enzyme indoleamine 2,3-dioxygenase (IDO), which activates CD8+ T cells in the tumour and induces apoptosis of regulatory T cells (T(reg) cells), thereby enhancing the immunotherapeutic effect in a mouse model (88).